About Kardigan, Inc.

Kardigan, Inc. is a clinical-stage precision therapeutics company, which engages in developing medicines that target the root cause of specific cardiovascular diseases where no approved treatments exist. It combines clinical-stage drug programs with artificial intelligence, real-world patient data, and analytics through its “Cardiac Intelligence” platform to accelerate research and improve treatment outcomes. The company was founded by Tassos E. Gianakakos, Jay Edelberg, Bob McDowell, Leslie Leinwand, and Elizabeth McNally in August 2023 and is headquartered in Princeton, NJ.

Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Employees: 241
Price: $15.02
Previous close: $14.52
Market capitalization: $1.3B
Volume: 654,262
P/E ratio: -6.79
52-week low: $14.24
52-week high: $27.00

Additional performance and financial-statement views load in the interactive application.

Market information is provided for research and visualization and is not investment advice.